Preparation for treating thrombocytopenic purpura caused by blood stasis obstructing collaterals and preparation method

A technology of blood stasis blocking collaterals and platelets, applied in medical preparations containing active ingredients, blood diseases, pharmaceutical formulations, etc., can solve the problems of lack of targeted drugs, insignificant effects, allergic reactions, etc., to improve bioavailability , good safety, the effect of improved dissolution

Inactive Publication Date: 2017-12-29
天津市善济宏兴科技发展有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are many types of drugs currently used clinically for the treatment of thrombocytopenic purpura, because there are many factors that cause thrombocytopenic purpura, and there are many types of thrombocytopenic purpura, these drugs are not targeted, and the course of treatment is relatively short. Longer, and some drugs have certain side effects or allergic reactions, so after taking it, the effect is not obvious for the treatment of thrombocytopenic purpura caused by blood stasis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation for treating thrombocytopenic purpura caused by blood stasis obstructing collaterals and preparation method
  • Preparation for treating thrombocytopenic purpura caused by blood stasis obstructing collaterals and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] The traditional Chinese medicine compound preparation provided in this example for the treatment of thrombocytopenic purpura caused by blood stasis blocking collaterals is made from the following pharmaceutical raw materials in terms of weight ratio:

[0014] Rehmannia 9 Salvia 9 Angelica 6 Paeoniae Rubra 9 Safflower 6

[0015] Moutan Bark 6 Rudder 9 Milletah 9 Eupatorium 6 Raw Licorice 4

[0016] The preparation method of the traditional Chinese medicine compound preparation for treating thrombocytopenic purpura caused by blood stasis blocking collaterals is to weigh and mix the above-mentioned medicinal raw materials according to the proportion, then add water to soak for 25 minutes, then decoct for 30 minutes, filter After removing the slag, the traditional Chinese medicine compound preparation for treating thrombocytopenic purpura caused by blood stasis and obstruction of collaterals can be prepared.

[0017] In addition, the traditional Chinese medicine compound p...

Embodiment 2

[0019] The traditional Chinese medicine compound preparation provided in this example for the treatment of thrombocytopenic purpura caused by blood stasis blocking collaterals is made from the following pharmaceutical raw materials in terms of weight ratio:

[0020] Rehmannia 24 Salvia 24 Angelica 15 Radix Paeoniae Rubra 24 Safflower 15

[0021] Cortex Moutan 15 Rubia 24 Millipede 24 Eupatorium 15 Raw Licorice 10

[0022] The preparation method is the same as in Example 1.

Embodiment 3

[0024] The traditional Chinese medicine compound preparation provided in this example for the treatment of thrombocytopenic purpura caused by blood stasis blocking collaterals is made from the following pharmaceutical raw materials in terms of weight ratio:

[0025] Rehmannia 12 Salvia 12 Angelica 8 Radix Paeoniae Rubra 12 Safflower 8

[0026] Moutan Bark 8 Rudder 12 Milletah 12 Eupatorium 8 Raw Licorice 5

[0027] The preparation method is the same as in Example 1.

[0028] The traditional Chinese medicine compound preparation for treating thrombocytopenic purpura caused by blood stasis blocking collaterals provided by the invention is brown to brown in color; light in breath and slightly bitter in taste. In order to verify the therapeutic effect of this traditional Chinese medicine compound preparation, the present inventor has carried out systematic clinical observation on 280 patients suffering from blood stasis blocking collateral type thrombocytopenic purpura by using t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation for treating thrombocytopenic purpura caused by blood stasis obstructing collaterals and a preparation method. The preparation is prepared from the following pharmaceutical raw materials in percentage by weight: 24% of radix rehmanniae recen, 24% of salvia miltiorrhiza, 15% of Chinese angelica, 24% of radix paeoniae rubra, 15% of carthamus tinctorius, 15% of cortex moutan radicis, 24% of rubia cordifolia, 24% of caulis spatholobi, 15% of herba lycopi and 10% of raw liquorice. According to the preparation, active ingredients in the pharmaceutical raw materials are extracted by a water cooking extraction method; the activity of the active ingredients are kept; the dissolubility of the active ingredients in the medicine can be improved greatly; the medicine absorption is facilitated, so that the bioavailability of the preparation can be improved. In addition, the medicine is a pure traditional Chinese medicine compound preparation, so that no toxic and/or side effects are generated after a patient takes the medicine for a long term, and the medicine is good in safety. In addition, the preparation method is simple in technology and convenient to operate.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation and a preparation method thereof, in particular to a traditional Chinese medicine compound preparation and a preparation method for treating thrombocytopenic purpura caused by blood stasis blocking collaterals made from traditional Chinese medicine. Background technique [0002] Thrombocytopenic purpura is a common bleeding disorder. Can be divided into two kinds of primary and secondary. Most of the primary ones are caused by autoimmunity, while the secondary ones can be caused by a variety of reasons, and the clinical manifestations of the two are similar. Whether primary or secondary, thrombocytopenic purpura is clinically characterized by petechiae and ecchymosis on the skin and mucous membranes, or internal bleeding, and an absolute decrease in platelet count. category. Although there are many types of drugs currently used clinically for the treatment of thrombocytopenic purpur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/804A61P7/04
CPCA61K36/232A61K36/286A61K36/484A61K36/486A61K36/53A61K36/537A61K36/65A61K36/71A61K36/74A61K36/804A61K2236/331A61K2300/00
Inventor 马力王维蔚齐燕松
Owner 天津市善济宏兴科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap